Private Equity Firm Profile
Bourne Partners Strategic Capital’s most common sectors for investment arelife science (80%) and healthcare services (20%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (60%) and divestiture (20%). In total, Bourne Partners Strategic Capital has invested in 3 US states and 3 different countries. Its largest (disclosed) acquisition occurred in 2017 when it acquired Inova Pharmaceuticals Pte for $930M.
In the last 3 years, Bourne Partners Strategic Capital has exited 2 companies. The Firm’s most common exit type is secondary buyout (100%). Bourne Partners Strategic Capital’s largest (disclosed) exit occurred in 2022 when it sold Inova Pharmaceuticals Pte for $1.4B.
Subscribe to Mergr to view Bourne Partners Strategic Capital’s full profile and discover more small private equity firm investors just like it.
M&A Summary
-
M&A Total Activity7
- M&A Buy Activity5
- M&A Sell Activity2
- Total Sectors Invested 2
- Total Countries Invested 3
- M&A Buy/Sell Connections 5
Unlimited Searches
